Cargando…

Validation of the european drug addiction prevention trial questionnaire (EU-DAP) for substance use screening and to assess risk and protective factors among adolescents in chile

INTRODUCTION: Substance use is highly prevalent among Chilean adolescents, and the damage it causes at the neurobiological, psychological, and social levels is well known. However, there are no validated screening instruments that also assess risk and protective factors for this Chilean population....

Descripción completa

Detalles Bibliográficos
Autores principales: Gaete, J., Ramirez, S., Gana, S., Godoy, M., Valenzuela, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470905/
http://dx.doi.org/10.1192/j.eurpsy.2021.258
_version_ 1784788944088465408
author Gaete, J.
Ramirez, S.
Gana, S.
Godoy, M.
Valenzuela, M.
author_facet Gaete, J.
Ramirez, S.
Gana, S.
Godoy, M.
Valenzuela, M.
author_sort Gaete, J.
collection PubMed
description INTRODUCTION: Substance use is highly prevalent among Chilean adolescents, and the damage it causes at the neurobiological, psychological, and social levels is well known. However, there are no validated screening instruments that also assess risk and protective factors for this Chilean population. OBJECTIVES: To evaluate the psychometric properties of the European Drug Addiction Prevention Trial Questionnaire (EU-Dap). METHODS: A cross-sectional study was carried out in 13 schools in Santiago of Chile. The sample included 2,261 adolescents of 10 to 14 years old. The linguistic and cultural adaptation was conducted using focus groups, the construct validity was evaluated using confirmatory factor analysis, and measures of its reliability were also determined. Furthermore, the associations regarding risk and protective factors with substance use were explored. RESULTS: Substance use questions were well understood by adolescents. Regarding the subscales of risk and protective factors, they needed some changes, and once completed, all new subscales had good or adequate goodness of fit adjustment. Regarding reliability, all of the new subscales had good or acceptable internal consistency according to the omega coefficient (range from 0.69 to 0.89). Finally, most of the risk and protective factors measured by the questionnaire were strongly associated with different substance use outcomes, especially those related to positive and negative beliefs or attitudes towards drugs, normative beliefs, and refusal skills. CONCLUSIONS: The current findings suggest that the EU-Dap questionnaire is a valid and reliable instrument, and it may help to evaluate the effectiveness of preventive interventions in the future. DISCLOSURE: No significant relationships.
format Online
Article
Text
id pubmed-9470905
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-94709052022-09-29 Validation of the european drug addiction prevention trial questionnaire (EU-DAP) for substance use screening and to assess risk and protective factors among adolescents in chile Gaete, J. Ramirez, S. Gana, S. Godoy, M. Valenzuela, M. Eur Psychiatry Abstract INTRODUCTION: Substance use is highly prevalent among Chilean adolescents, and the damage it causes at the neurobiological, psychological, and social levels is well known. However, there are no validated screening instruments that also assess risk and protective factors for this Chilean population. OBJECTIVES: To evaluate the psychometric properties of the European Drug Addiction Prevention Trial Questionnaire (EU-Dap). METHODS: A cross-sectional study was carried out in 13 schools in Santiago of Chile. The sample included 2,261 adolescents of 10 to 14 years old. The linguistic and cultural adaptation was conducted using focus groups, the construct validity was evaluated using confirmatory factor analysis, and measures of its reliability were also determined. Furthermore, the associations regarding risk and protective factors with substance use were explored. RESULTS: Substance use questions were well understood by adolescents. Regarding the subscales of risk and protective factors, they needed some changes, and once completed, all new subscales had good or adequate goodness of fit adjustment. Regarding reliability, all of the new subscales had good or acceptable internal consistency according to the omega coefficient (range from 0.69 to 0.89). Finally, most of the risk and protective factors measured by the questionnaire were strongly associated with different substance use outcomes, especially those related to positive and negative beliefs or attitudes towards drugs, normative beliefs, and refusal skills. CONCLUSIONS: The current findings suggest that the EU-Dap questionnaire is a valid and reliable instrument, and it may help to evaluate the effectiveness of preventive interventions in the future. DISCLOSURE: No significant relationships. Cambridge University Press 2021-08-13 /pmc/articles/PMC9470905/ http://dx.doi.org/10.1192/j.eurpsy.2021.258 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Gaete, J.
Ramirez, S.
Gana, S.
Godoy, M.
Valenzuela, M.
Validation of the european drug addiction prevention trial questionnaire (EU-DAP) for substance use screening and to assess risk and protective factors among adolescents in chile
title Validation of the european drug addiction prevention trial questionnaire (EU-DAP) for substance use screening and to assess risk and protective factors among adolescents in chile
title_full Validation of the european drug addiction prevention trial questionnaire (EU-DAP) for substance use screening and to assess risk and protective factors among adolescents in chile
title_fullStr Validation of the european drug addiction prevention trial questionnaire (EU-DAP) for substance use screening and to assess risk and protective factors among adolescents in chile
title_full_unstemmed Validation of the european drug addiction prevention trial questionnaire (EU-DAP) for substance use screening and to assess risk and protective factors among adolescents in chile
title_short Validation of the european drug addiction prevention trial questionnaire (EU-DAP) for substance use screening and to assess risk and protective factors among adolescents in chile
title_sort validation of the european drug addiction prevention trial questionnaire (eu-dap) for substance use screening and to assess risk and protective factors among adolescents in chile
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470905/
http://dx.doi.org/10.1192/j.eurpsy.2021.258
work_keys_str_mv AT gaetej validationoftheeuropeandrugaddictionpreventiontrialquestionnaireeudapforsubstanceusescreeningandtoassessriskandprotectivefactorsamongadolescentsinchile
AT ramirezs validationoftheeuropeandrugaddictionpreventiontrialquestionnaireeudapforsubstanceusescreeningandtoassessriskandprotectivefactorsamongadolescentsinchile
AT ganas validationoftheeuropeandrugaddictionpreventiontrialquestionnaireeudapforsubstanceusescreeningandtoassessriskandprotectivefactorsamongadolescentsinchile
AT godoym validationoftheeuropeandrugaddictionpreventiontrialquestionnaireeudapforsubstanceusescreeningandtoassessriskandprotectivefactorsamongadolescentsinchile
AT valenzuelam validationoftheeuropeandrugaddictionpreventiontrialquestionnaireeudapforsubstanceusescreeningandtoassessriskandprotectivefactorsamongadolescentsinchile